{"id":97060,"date":"2025-12-04T13:41:08","date_gmt":"2025-12-04T13:41:08","guid":{"rendered":"https:\/\/www.europesays.com\/se\/97060\/"},"modified":"2025-12-04T13:41:08","modified_gmt":"2025-12-04T13:41:08","slug":"danmark-utreder-om-novo-nordisk-ska-betala-wegovy-ersattningar-for-ogonsjukdomar-dr","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/97060\/","title":{"rendered":"Danmark utreder om Novo Nordisk ska betala Wegovy-ers\u00e4ttningar f\u00f6r \u00f6gonsjukdomar &#8211; DR"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Den danska regeringen l\u00e5ter Kammeradvokaten utreda om ers\u00e4ttning f\u00f6r allvarliga synskador kopplade till Wegovy och Ozempic kan kr\u00e4vas av Novo Nordisk, rapporterar DR.\n <\/p>\n<p>I dag betalar staten via Dansk Patienterstatning, men myndigheten vill att juridiska m\u00f6jligheter att l\u00e5ta l\u00e4kemedelsbolaget st\u00e5 f\u00f6r notan pr\u00f6vas.\n <\/p>\n<p>Hittills har 58 danskar ans\u00f6kt om ers\u00e4ttning kopplad till misst\u00e4nkta biverkningar. \u00c4n s\u00e5 l\u00e4nge har fyra patienter f\u00e5tt ers\u00e4ttningar om 800 000 danska kronor.\n <\/p>\n<p>Novo Nordisk kommenterar inte utredningen.<br \/>\n <br class=\"col-start-2\"\/><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">newsroom@finwire.se<br \/>\n <br class=\"col-start-2\"\/><br \/>\n Nyhetsbyr\u00e5n Finwire<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\"><a class=\"text-primary-90 underline hover:text-primary-110 hover:no-underline\" rel=\"noopener noreferrer nofollow\" target=\"_blank\" href=\"https:\/\/www.dr.dk\/nyheder\/indland\/minister-undersoeger-om-novo-skal-betale-erstatninger-efter-alvorlige-wegovy-bivirkninger\">L\u00e4s mer p\u00e5 Finwire<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Den danska regeringen l\u00e5ter Kammeradvokaten utreda om ers\u00e4ttning f\u00f6r allvarliga synskador kopplade till Wegovy och Ozempic kan kr\u00e4vas&hellip;\n","protected":false},"author":2,"featured_media":77249,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65],"tags":[72,70,71,34,31,33,32,30],"class_list":{"0":"post-97060","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ekonomi","8":"tag-business","9":"tag-economy","10":"tag-ekonomi","11":"tag-se","12":"tag-svenska","13":"tag-sverige","14":"tag-sweden","15":"tag-swedish"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115661588753080724","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/97060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=97060"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/97060\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/77249"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=97060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=97060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=97060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}